Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

• Status: Completed
• Trial end date: 2021-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test non-inferiority of spectral CT with low contrast agent and low radiation dose, compare to conventional liver CT in surveillance of hepatocellular carcinoma (HCC) in high-risk patient.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital

Criteria

Inclusion Criteria:

• Liver cirrhosis

• Tumor marker (aFP, PIVKA) elevation

• Nodular lesion on USG

• Received RFA for HCC

Exclusion Criteria:

• hypersensitivity at iodine

• GFR under 30

• BMI over 30

• Nursing or pregnant women

• enrolled the other study